In recent times, as concerns over respiratory illnesses have heightened, one virus that parents need to be mindful of is adenovirus. Adenovirus is a common respiratory virus that can cause a range ...

The FDA advised that the on-going VIRAGE Phase 2b study should not be expanded into a Phase 3 study; rather, the optimal path forward for the VCN-01 PDAC program is to conduct a stand-alone Phase 3 ...

The companies are testing a recombinant protein-based coronavirus ... in clinical trials against coronavirus. These are an adenovirus vector-based vaccine being developed in China by CanSino ...

Theriva Biologics, Inc. recently disclosed the outcomes of a Type D meeting with the U.S. Food and Drug Administration (FDA), outlining details regarding the design of a Phase 3 clinical study ...

The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled study to determine the relative efficacy, safety, and immunogenicity of Vaxart’s oral pill COVID-19 vaccine ...

Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based ... and creations for oral vaccination using adenovirus and TLR3 agonists.

The evidence for the authors' claims is convincing, combining state-of-the-art conditional gene deletion in the mouse lens with histological and molecular approaches. This work should be of great ...

The agreement covers the manufacturing of standard BCG (sBCG) that is currently approved for use outside the U.S., as well as a next-generation recombinant BCG (iBCG) undergoing testing ...

Correspondence to: Dr G J Gores Mayo Clinic College of Medicine, 200 First St SW, Rochester, Minnesota 55905, USA; gores.gregorymayo.edu Apoptosis is a highly organised and genetically controlled type ...